These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 16248789)

  • 1. Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.
    Curtin JF; King GD; Candolfi M; Greeno RB; Kroeger KM; Lowenstein PR; Castro MG
    Curr Top Med Chem; 2005; 5(12):1151-70. PubMed ID: 16248789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy and targeted toxins for glioma.
    Castro MG; Candolfi M; Kroeger K; King GD; Curtin JF; Yagiz K; Mineharu Y; Assi H; Wibowo M; Ghulam Muhammad AK; Foulad D; Puntel M; Lowenstein PR
    Curr Gene Ther; 2011 Jun; 11(3):155-80. PubMed ID: 21453286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for brain tumors: basic developments and clinical implementation.
    Assi H; Candolfi M; Baker G; Mineharu Y; Lowenstein PR; Castro MG
    Neurosci Lett; 2012 Oct; 527(2):71-7. PubMed ID: 22906921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives in glioma immunotherapy.
    Daga A; Bottino C; Castriconi R; Gangemi R; Ferrini S
    Curr Pharm Des; 2011; 17(23):2439-67. PubMed ID: 21827420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma.
    Li Y; Ma Y; Wu Z; Xie R; Zeng F; Cai H; Lui S; Song B; Chen L; Wu M
    Front Immunol; 2021; 12():790674. PubMed ID: 34899760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment.
    Pearson JRD; Cuzzubbo S; McArthur S; Durrant LG; Adhikaree J; Tinsley CJ; Pockley AG; McArdle SEB
    Front Immunol; 2020; 11():582106. PubMed ID: 33178210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoengineering in glioblastoma imaging and therapy.
    Zanganeh S; Georgala P; Corbo C; Arabi L; Ho JQ; Javdani N; Sepand MR; Cruickshank K; Campesato LF; Weng CH; Hemayat S; Andreou C; Alvim R; Hutter G; Rafat M; Mahmoudi M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1575. PubMed ID: 31407522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.
    Candolfi M; Kroeger KM; Muhammad AK; Yagiz K; Farrokhi C; Pechnick RN; Lowenstein PR; Castro MG
    Curr Gene Ther; 2009 Oct; 9(5):409-21. PubMed ID: 19860655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
    Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
    Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing immunotherapeutic strategies to target brain tumors.
    Lieberman NA; Moyes KW; Crane CA
    Expert Rev Anticancer Ther; 2016 Jul; 16(7):775-88. PubMed ID: 27253692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.
    Haque A; Banik NL; Ray SK
    Neurochem Res; 2007 Dec; 32(12):2203-9. PubMed ID: 17676389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
    Medikonda R; Pant A; Lim M
    Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.
    Neagu MR; Reardon DA
    Curr Treat Options Oncol; 2015 Nov; 16(11):54. PubMed ID: 26454859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future strategies for the treatment of malignant brain tumors.
    Castro MG; Cowen R; Williamson IK; David A; Jimenez-Dalmaroni MJ; Yuan X; Bigliari A; Williams JC; Hu J; Lowenstein PR
    Pharmacol Ther; 2003 Apr; 98(1):71-108. PubMed ID: 12667889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
    Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
    Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy and targeted toxins for glioma.
    King GD; Curtin JF; Candolfi M; Kroeger K; Lowenstein PR; Castro MG
    Curr Gene Ther; 2005 Dec; 5(6):535-57. PubMed ID: 16457645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival.
    Belmans J; Van Woensel M; Creyns B; Dejaegher J; Bullens DM; Van Gool SW
    Sci Rep; 2017 Oct; 7(1):13902. PubMed ID: 29066810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipilimumab: an investigational immunotherapy for glioblastoma.
    Youssef G; Dietrich J
    Expert Opin Investig Drugs; 2020 Nov; 29(11):1187-1193. PubMed ID: 32945231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy in brain tumors].
    De Carli E; Delion M; Rousseau A
    Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.